SIRO Clinpharm chooses Microsoft Office 365 to improve productivity
Office 365 provides functionality with features that support the needs of SIRO Clinpharm, helping employees stay productive and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40
GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule
Marck Biosciences takes private equity route with Tata Capital
To invest Rs 80 crores in new project
Lonza commences manufacturing in cGMP Viral Immunotherapy manufacturing suites
Completes the tech transfer process for a new virally-transfected T-cell product
Medicines Compendium expands global reach through new expert committees, enhanced website
Experts from Argentina, Bangladesh, Brazil, China, Korea, Pakistan and the UK reflect growth of the MC
Lonza and Novoset launches thermoset polyimides for electronic and aerospace industries
To address shortcomings of conventional high temperature polyimides currently available in the market
Lupin posts net profit of 42.6 per cent in Q3 of 2012-13
EBITDA margins grew by 67.6 per cent to Rs. 6,314 million
Global Drug Facility appoints Dr Joel Keravec as manager
Has 22 years of experience as a public health consultant
Patent Gurukul, Pravin Gandhi College of Law to organise brainstorming session on traditional…
Session to be held in Mumbai on February 15, 2013